Court Rules Government to Abort Unilateral Disposition on Medical Insurance Drug Pricing

The recent ruling from the Seoul Administration Court to abort the unilateral disposition by the government to lower the medical insurance prices for certain ethical medications is creating repercussions in the domestic pharmaceutical industry.

On January 25th, the Seoul Administration Court made its ruling decision in favor of Pharmacia Korea, now Pfizer Korea, on its claim against the Mini...